Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cleaner Air for Lower Cardiometabolic Risk

NCT: NCT05994937 · COMPLETED

NCT IDNCT05994937
StatusCOMPLETED
Start Date2023-12-26
Completion2026-04-22

Brief Summary

The purpose of this interventional sham-controlled pilot study is to study the effects of using portable air cleaners (PACs) in outpatient adults with prediabetes. The primary aims are to determine the effect PAC's have on glycemic variability and the concentrations of circulating biomarkers of inflammation.

Frequently Asked Questions

What is Cleaner Air for Lower Cardiometabolic Risk?

Cleaner Air for Lower Cardiometabolic Risk is a clinical trial registered under NCT05994937. Current status: COMPLETED.

What is the status of NCT05994937?

The current status of NCT05994937 (Cleaner Air for Lower Cardiometabolic Risk) is: COMPLETED.

When did Cleaner Air for Lower Cardiometabolic Risk start?

Cleaner Air for Lower Cardiometabolic Risk started on 2023-12-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.